PCN195 COST COMPARISON BETWEEN LEUPROLIDE 3-MONTH FORMULATION AND GOSERELIN 1-MONTH FORMULATION AS ADJUVANT ENDOCRINE THERAPY IN POST-MASTECTOMY, PREMENOPAUSAL WOMEN WITH EARLY-STAGE, ESTROGEN RECEPTOR-POSITIVE BREAST CANCER WHO ARE AT MODE ...

Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.391
https://www.valueinhealthjournal.com/article/S1098-3015(19)32769-X/fulltext
Section Title :
Section Order : 10321
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32769-X&doi=10.1016/j.jval.2019.09.391
HEOR Topics :
Tags :
Regions :